期刊文献+

精准医学时期儿科神经可治性遗传病的个体化诊治进展 被引量:1

Advances in personalized diagnosis and treatment of treatable genetic diseases of pediatric neurology in preci-sion medicine period
原文传递
导出
摘要 21世纪精准医学的发展引领了一个新的医学时代,为特色疾病的诊治带来了一套精准的治疗方案。精准医学时期兴起的遗传病检测新技术基因二代测序技术和拷贝数变异检测技术为小儿神经系统遗传病、罕见病的诊治提供了巨大帮助,尤其为肌酸缺乏综合征、吡哆醇依赖性癫痫、1型葡萄糖转运体缺陷综合征、婴儿游走性部分性癫痫、GRIN2A相关性早发性癫痫脑病、KCNQ2相关性癫痫等疾病提供了个体化药物治疗。精准医学的到来,无疑为小儿神经系统遗传病、罕见病的诊治带来了划时代的革命。 The development of precision medicine in 21st century has accelerated a new area of medicine, bringing a precise project of diagnosis and treatment. The new techniques for genetic diseases including next generation sequencing and copy number variation deteetion technology have facilitated the diagnosis and treatment of genetic and rare diseases in children's neural system, providing a new directed therapies especially for ereatine deficiency syn- dromes, pyridoxine dependent epilepsy, glucose transporter type 1 deficiency syndrome, malignant migrating partial sei- zures in infancy, GRIN2A - related early - onset epileptic encephalopathy, KCNQ2 - related epilepsies. With the new area of precision medicine arrival, an epoch - making revolution for the diagnosis and treatment of genetic and rare diseases in children's neural system is coming towards us.
出处 《中华实用儿科临床杂志》 CSCD 北大核心 2016年第12期951-955,共5页 Chinese Journal of Applied Clinical Pediatrics
关键词 精准医学 遗传病 诊断 治疗 Precision medicine Genetic disease Diagnosis Treatment
  • 相关文献

参考文献4

二级参考文献23

  • 1Gospe SM Jr. Pyridoxine-dependent seizures:new genetic and biochemical clues to help with diagnosis and treatment[J].Current Opinion in Neurology,2006,(02):148-153.doi:10.1097/01.wco.0000218230.81301.12.
  • 2Baxter P. Pyridoxine-dependent and pyridoxine-responsive seizures[J].Developmental Medicine and Child Neurology,2001,(06):416-420.doi:10.1017/S0012162201000779.
  • 3Plecko B,St(o)ckler-Ipsiroglu S,Paschke E. Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy[J].Annals of Neurology,2000,(01):121-125.
  • 4Struys EA,Jakobs C. Alpha-aminoadipic semialdehyde is the biomarker for pyridoxine dependent epilepsy caused by alpha-aminoadipic semialdehyde dehydrogenase deficiency[J].Molecular Genetics and Metabolism,2007,(04):405.
  • 5Mills PB,Struys E,Jakobs C. Mutations in antiquitin in individuals with pyridoxine-dependent seizures[J].Nature Medicine,2006,(03):307-309.
  • 6Ebinger M,Schultze C,K(o)nig S. Demographics and diagnosis of pyridoxinedependent seizures[J].Journal of Pediatrics,1999,(06):795-796.
  • 7Been JV,Bok LA,Andriessen P. Epidemiology of pyridoxine dependent seizures in the Netherlands[J].Archives of Disease in Childhood,2005,(12):1293-1296.doi:10.1136/adc.2005.075069.
  • 8Baxter P. Epidemiology of pyridoxine dependent and pyridoxine responsive seizures in the UK[J].Archives of Disease in Childhood,1999,(05):431-433.doi:10.1136/adc.81.5.431.
  • 9Yeghiazaryan NS,Zara F,Capovilla G. Pyridoxine-dependent epilepsy:an under-recognised cause of intractable seizures[J].Journal of Paediatrics and Child Health,2012,(03):E113-E115.
  • 10Bass NE,Wyllie E,Cohen B. Pyridoxine-dependent epilepsy:the need for reoeated pyridoxine trials and the risk of severe electrocerebral suppression with intravenous pyridoxine infusion[J].Journal of Child Neurology,1996,(05):422-424.

共引文献61

同被引文献20

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部